Combination Therapy Approaches to Enhance the Efficacy of ERV-Targeting Vaccines in Cancer

Area of Science:

• Genomics
• Immunology
• Oncology

Background:

• Endogenous retroviruses (ERVs) are integrated remnants of ancient retroviral infections in the human germline.
• While often mutated, some ERVs retain functional open reading frames encoding retroviral proteins.
• ERVs are epigenetically silenced in healthy tissues but aberrantly expressed in various cancers.

Purpose of the Study:

• To review the role of ERVs in cancer development and progression.
• To summarize current strategies for targeting ERVs therapeutically.
• To discuss challenges and potential combination therapies for ERV-based cancer treatments.

Main Methods:

• Literature review of endogenous retroviruses in cancer.
• Analysis of ERV immunogenicity and expression patterns in neoplastic tissues.
• Evaluation of emerging ERV-targeting therapeutic strategies and vaccine approaches.

Main Results:

• ERVs are immunogenic and show elevated expression in cancer cells compared to normal tissues.
• Aberrant epigenetic regulation drives ERV expression in multiple cancer types.
• Several strategies are being developed to target ERVs for cancer therapy.

Conclusions:

• ERVs represent promising targets for cancer immunotherapy due to their cancer-specific expression and immunogenicity.
• Further research into ERV-targeting strategies, including combination therapies, is warranted to enhance antitumor efficacy.